There is evidence suggesting that nitric oxide (NO) may play an important r
ole in dopamine (DA) cell death. Thus, the aim of this study waste investig
ate the effects of NO on apoptosis and functionality of DA neurones and gli
al cells. The experiments were carried out in neuronal-enriched midbrain cu
ltures treated with the NO donor diethylamine-nitric oxide complexed sodium
(DEA-NO). DEA-NO, at doses of 25 and 50 muM, exerted neurotrophic effects
on dopamine cells, increasing the number of tyrosine hydroxylase positive (
TH+) cells, TH+ neurite processes, DA levels and [H-3]DA uptake. A dose of
25 muM DEA-NO protected DA cells from apoptosis. in addition, it induced de
novo TH synthesis and increased intracellular reduced glutathione (GSH) le
vels, indicating a possible neuroprotective role for GSH. However, in doses
ranging from 200 to 400 muM, DEA-NO decreased TH+ cells, DA levels, [H-3]D
A uptake and the numberer mature oligodendrocytes (O1(+) cells). No changes
in either the amount or morphology of astrocytes and glial progenitors wer
e detected. A dose- and time-dependent increase in apoptotic cells in the D
EA-NO-treated culture was also observed, with a concomitant increase in the
proapoptotic Bax protein levels and a reduction in the ratio between Bcl-x
L and Bcl-xS proteins. In addition, DEA-NO induced a dose- and time-depende
nt increase in necrotic cells. 1H-[1,2,4]oxadiazolo[4,3a]quinoxaline-1-one
(ODQ, 0.5 muM), a selective guanylate cyclase inhibitor, did not revert the
NO-induced effect on [H-3]DA uptake. Glia-conditioned medium, obtained fro
m fetal midbrain astrocyte cultures, totally protected neuronal-enriched mi
dbrain cultures from NO-induced apoptosis and rescued [H-3]DA uptake and TH
+ cell number. In conclusion, our results show that low NO concentrations h
ave neurotrophic effects on DA cells via a cGMP-independent mechanism that
may implicate up-regulation of GSH. On the other hand, higher levels of NO
induce cell death in both dopamine neurones and mature oligodendrocytes tha
t is totally reverted by soluble factors released from glia.